Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Potent, topically active glucocorticoid from RPR shows potential for bronchial asthma

Oct. 24, 1997

Abbott develops inhibitors of LT biosynthesis

Oct. 24, 1997

TBC-1269 enters phase II for treatment and prevention of asthma

Oct. 24, 1997

Oxis Turbuhaler launched in U.K.

Oct. 23, 1997

Bradykinin antagonists from Pfizer

Oct. 23, 1997

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Toxicity studies reported for new expectorant from SS Pharm.

Oct. 17, 1997

Byk Gulden describes new agents for asthma

Oct. 17, 1997

CRP-derived peptides for chronic inflammatory disorders developed at Yeda

Oct. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...